Author:
Virović-Jukić Lucija,Forgač Jelena,Ogresta Doris,Filipec-Kanižaj Tajana,Mrzljak Anna
Publisher
Springer International Publishing
Reference178 articles.
1. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL–EASD–EASO clinical practice guidelines for the management of nonalcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.
2. Bedossa P, Poynard T, French METAVIR Cooperative Study Group. An algorithm for grading activity in chronic hepatitis C. Hepatology. 1996;24:289–93.
3. Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017;9(16):715–32.
4. Duvnjak M, Lerotić I, Baršić N, Tomašić V, VirovićJukić L, Velagić V. Pathogenesis and management issues for nonalcoholic fatty liver disease. World J Gastroenterol. 2007;13(34):4539–50.
5. Geisler CE, Renquist BJ. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. J Endocrinol. 2017;234:R1–R21.